Elina Koustoumpardi

Senior Consultant
Elina Koustoumpardi Antitrust Competition Charles River Associates

Elina Koustoumpardi joined CRA (formerly Lexecon) in 2002. During her tenure, she has advised clients in mergers, Art. 101 & 102 cases as well as follow-on damages cases arising from anti-competitive conduct both before the EU and national competition authorities in Europe, China and South Africa, in sectors ranging from pharmaceuticals, carton packaging, aviation, mining and telecoms.

In her more recent work she has provided economic advice to a large carton packaging producer being investigated for anti-competitive practices in China, has provided economic advice and supporting analysis in a number of pharmaceutical mergers including Novartis/GSK, Pfizer/Hospira, Teva/Mylan and co-authored a study on the economic impacts of changing exemption provisions during patent and SPC protection of pharmaceuticals in Europe.

Selected engagements

  • 01
    CRA Competition team advises on Microsoft’s acquisition of Activision Blizzard across jurisdictions worldwide
    On October 13, 2023, the Competition and Markets Authority (CMA) announced that it would clear Microsoft’s acquisition of Activision Blizzard – subject to...
    View engagement
  • 02
    European Commission closes investigations into retail alliances
    On 13 July 2023, the European Commission announced its decision to close its preliminary investigations into certain practices of two European retail...
    View engagement
  • 03
    CMA clears Capco’s acquisition of Shaftesbury
    On 22 February 2023, the CMA unconditionally cleared Capco’s acquisition of Shaftsbury after a Phase I review. Capco and Shaftesbury are UK-registered Real...
    View engagement


Get In Touch